Global Influenza (Flu) Antiviral Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Influenza (Flu) Antiviral Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Antiviral drugs are a class of drugs for the specific treatment of viral infections.
Influenza (Flu) Antiviral Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Influenza (Flu) Antiviral Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Influenza (Flu) Antiviral Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Influenza (Flu) Antiviral Drugs key companies include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc. Pfizer, Roche, Sanofi are top 3 players and held % share in total in 2022.
Influenza (Flu) Antiviral Drugs can be divided into Penetration and Dehulling Inhibitors, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors and Protein Inhibitors, etc. Penetration and Dehulling Inhibitors is the mainstream product in the market, accounting for % share globally in 2022.
Influenza (Flu) Antiviral Drugs is widely used in various fields, such as Hospital, Clinic, Household and Others, etc. Hospital provides greatest supports to the Influenza (Flu) Antiviral Drugs industry development. In 2022, global % share of Influenza (Flu) Antiviral Drugs went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Influenza (Flu) Antiviral Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Segment by Type
Penetration and Dehulling Inhibitors
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protein Inhibitors
Neuraminidase Inhibitors
Broad-spectrum Antiviral Drugs
Hospital
Clinic
Household
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Influenza (Flu) Antiviral Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Influenza (Flu) Antiviral Drugs introduction, etc. Influenza (Flu) Antiviral Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Influenza (Flu) Antiviral Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Influenza (Flu) Antiviral Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Influenza (Flu) Antiviral Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Influenza (Flu) Antiviral Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Influenza (Flu) Antiviral Drugs key companies include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc. Pfizer, Roche, Sanofi are top 3 players and held % share in total in 2022.
Influenza (Flu) Antiviral Drugs can be divided into Penetration and Dehulling Inhibitors, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors and Protein Inhibitors, etc. Penetration and Dehulling Inhibitors is the mainstream product in the market, accounting for % share globally in 2022.
Influenza (Flu) Antiviral Drugs is widely used in various fields, such as Hospital, Clinic, Household and Others, etc. Hospital provides greatest supports to the Influenza (Flu) Antiviral Drugs industry development. In 2022, global % share of Influenza (Flu) Antiviral Drugs went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Influenza (Flu) Antiviral Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Segment by Type
Penetration and Dehulling Inhibitors
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protein Inhibitors
Neuraminidase Inhibitors
Broad-spectrum Antiviral Drugs
Segment by Application
Hospital
Clinic
Household
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Influenza (Flu) Antiviral Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Influenza (Flu) Antiviral Drugs introduction, etc. Influenza (Flu) Antiviral Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Influenza (Flu) Antiviral Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices